Petkova-Parlapanska Kamelia, Draganova Valeria, Georgieva Ekaterina, Goycheva Petya, Nikolova Galina, Karamalakova Yanka
Medical Chemistry and Biochemistry Department, Medical Faculty, Trakia University, 11 Armeiska Str., 6000 Stara Zagora, Bulgaria.
Department of Otorhinolaryngology and Ophthalmology, Medical Faculty, Trakia University, 6000 Stara Zagora, Bulgaria.
Int J Mol Sci. 2025 Apr 17;26(8):3810. doi: 10.3390/ijms26083810.
This study investigates the association between diabetic retinopathy (DR) and its complication, diabetic macular edema (DME), and compared it with biomarkers of oxidative stress. This study aimed to compare the main indicators of the development of diabetic retinopathy measured as parameters of oxidative stress and compared to lipid oxidation, DNA damage, and cytokine levels and to monitor their quantitative manifestation in DME. This study evaluated 134 patients (62 males and 72 females; aged 62.10 ± 11.22 years) and divided them into two groups: type 2 diabetes mellitus with DR and type 2 diabetes mellitus with DME. All results were compared with healthy volunteers ( = 94) and showed that patients with DME had significantly higher levels of ROS, cytokine production, lipid oxidation, and DNA damage. In addition, patients with DME had decreased levels of nitric oxide (NO) and an impaired NO synthase (NOS) system ( < 0.05). These findings suggest that patients with DR and DME are unable to compensate for high levels of oxidative stress. Reduced NO levels in patients with DME may be due to impaired NO availability. This study highlights compromised oxidative status as a contributing factor to DME in patients with decompensated type 2 diabetes mellitus. An assessment of oxidative stress levels and inflammatory biomarkers may aid in the early detection and prediction of diabetic complications.
本研究调查了糖尿病视网膜病变(DR)及其并发症糖尿病性黄斑水肿(DME)之间的关联,并将其与氧化应激生物标志物进行比较。本研究旨在比较作为氧化应激参数测量的糖尿病视网膜病变发展的主要指标,并与脂质氧化、DNA损伤和细胞因子水平进行比较,以监测它们在DME中的定量表现。本研究评估了134例患者(62例男性和72例女性;年龄62.10±11.22岁),并将他们分为两组:患有DR的2型糖尿病患者和患有DME的2型糖尿病患者。所有结果均与健康志愿者(n = 94)进行比较,结果显示,患有DME的患者的活性氧(ROS)水平、细胞因子产生、脂质氧化和DNA损伤水平显著更高。此外,患有DME的患者的一氧化氮(NO)水平降低,一氧化氮合酶(NOS)系统受损(P < 0.05)。这些发现表明,患有DR和DME的患者无法代偿高水平的氧化应激。患有DME的患者中NO水平降低可能是由于NO可用性受损。本研究强调氧化状态受损是失代偿性2型糖尿病患者发生DME的一个促成因素。评估氧化应激水平和炎症生物标志物可能有助于糖尿病并发症的早期检测和预测。